Article

Screening of HRas, RRas and FOS as Potential Pharmacodynamic Candidates for the Treatment of Hepatocellular Carcinoma

2022-03-28

Abstract excerpt

<title>Abstract</title> <p>Hepatocellular carcinoma (HCC) is a deadly primary tumour that begins in hepatocytes. Tumour cell proliferation and progression is influenced by cellular components of the liver and their microenvironment. Pharmacodynamic (PD) biomarkers are biomolecules that demonstrate the effect of a therapeutic intervention on the affected organ and its microenvironment. PD biomarkers are used to st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c12a8d12-9363-5ecd-aadf-79d6cfaf4061
DOI: 10.21203/rs.3.rs-1453092/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Screening of HRas, RRas and FOS as Potential Pharmacodynamic Candidates for the Treatment of Hepatocellular CarcinomaDOI 10.21203/rs.3.rs-1453092/v1Read

Identification of Novel Biomarkers in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis and Experimental ValidationSemantic proximity Read

Identification of hub genes and potential drugs in hepatocellular carcinoma through integrated bioinformatics analysisSemantic proximity Read

In-silico Identification of Potential Therapeutic Targets against Virus Induced Hepatocellular CarcinomaSemantic proximity Read

Target prediction and potential application of dihydroartemisin on hepatocarcinomaSemantic proximity Read

Multi-Target Inhibition of Hepatocellular Carcinoma via DIBP from Glycyrrhiza uralensis: A Systems Biology and Experimental ApproachSemantic proximity Read

Integrative in-silico analysis on phytocompounds of Pajanelia longifolia against hepatocellular carcinoma: gene network target identification, molecular docking, simulation and ADMET profilingSemantic proximity Read

Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future DirectionsSemantic proximity Read

Comprehensive Analysis of the Expression and Prognosis of 12 Cytochrome P450s in Human Hepatocellular Carcinoma from the Perspective of Network PharmacologySemantic proximity Read

Proteomic profiling of advanced hepatocellular carcinoma identifies predictive signatures of response to treatmentsSemantic proximity Read

Elucidating the Multi-Target Mechanisms of Niclosamide in Hepatocellular Carcinoma through Network Pharmacology, Molecular Docking, and Molecular Dynamics SimulationsSemantic proximity Read

Molecular Pathways and Related Target Therapies in Liver CarcinomaSemantic proximity Read

Identifies Oncogene PDRG1 as a Potential Prognostic Biomarker in Hepatocellular Carcinoma: A Study Based on Bioinformatics AnalysisSemantic proximity Read